MORE►
biotech
Mei Mei Hu, co-founder and CEO of Vaxxinity [Photo: Vaxxinity]
Dallas-Based Vaxxinity Prepares for $100M IPO; Aims to Turn Immune Systems Into ‘Antibody Factories’
by David Seeley | Nov 8, 2021
Vaxxinity's COVID-19 vaccine candidate is "super safe and mild and doesn’t bring recipients down for a couple of days with flu-like symptoms," says the company's co-founder and CEO, Mei Mei Hu. Unlike mRNA vaccines from Modern and Pfizer, Vaxxinity says its protein peptide-based platform is based on tech that led to a vaccine for foot-and-mouth disease in livestock.
by Alex Edwards |
Oct 14, 2021
It's the San Franciso company's first office in Texas. Verily expects to hire as many as 115 employees by the end of 2022.
MORE►
by David Seeley |
Sep 22, 2021
Southlake-based OncoNano Medicine uses pH-sensitive nanoparticle technology to "light up" cancer for real-time surgical imaging. The multi-year collaboration will seek to uncover new cancer therapies that can benefit from OncoNano's technology.
OncoNano raised $50 million in Series B funding in June.
MORE►
by bionorthTX |
Sep 14, 2021
Deadline for nominations is Friday, September 17. The 2021 award, sponsored by BioLabs at Pegasus Park, will be presented on September 30 at the iC3 Life Science Summit.
The impact that Dr. Dennis K. Stone left on the DFW biotech industry is, without doubt, immeasurable, says BioNTX. Past recipients of the award that honors his memory are Phil Ralston, Lyda Hill, Darlene Boudreaux, Paul Dorman, and Hubert Zajicek.
MORE►
The main building at Pegasus Park.[Image: GFF]
Renovations Begin for BioLabs’ December Opening at Pegasus Park
by Alex Edwards | Aug 10, 2021
A mid-December opening is planned for BioLabs' first central U.S. location in Dallas. Inside the Biotech+ Hub at Pegasus Park, BioLabs will serve as the key operator of the biotech laboratory and 37,000-square-foot flexible life science coworking facility.
MORE►
by David Seeley |
Jun 22, 2021
Nanoscope Therapeutics successfully treated 11 patients blinded by advanced retinitis pigmentosa (RP). A single intravitreal injection produced positive results that persisted through one year. The startup plans a Phase 2b trial this summer and plans to develop gene therapies to treat more common retinal diseases—like dry age-related macular degeneration.
MORE►
by Alex Edwards |
Jun 17, 2021
The investment was led by Advantech Capital, a PE fund based in China that focuses on TMT, pharmaceuticals, and healthcare. This combined with the support from the Cancer Prevention and Research Institute of Texas (CPRIT), which granted OncoNano $9.97 million last year, will support Phase 3 clinical trials for the biotech's technology that can diagnose and treat cancer with high specificity.
MORE►
by Alex Edwards |
Mar 8, 2021
As CMO at the Dallas-based biotech, Jessica Hilton is part of a team working to launch the first-ever long-lasting cleaner that can fight COVID-19. It's a job she took during the middle of the global pandemic—and though her home life looks a little different, the mom of three is managing it all through a deep-seeded passion and supportive family.
MORE►
Doloromics Co-Founders Candler Paige, Dr. Theodore Price, and Jackson Brougher [Photos: Doloromics]
‘Highly Selective’ Illumina Accelerator Picks Dallas-Based Doloromics for its Second Funding Cycle
by Alex Edwards | Feb 16, 2021
Doloromics, a local therapeutics discovery startup that uses technology to find better ways to treat chronic pain, is one of nine companies selected.
MORE►
by Quincy Preston and Sandra Engelland |
Feb 11, 2021
Here are 32 North Texas startups that successfully pulled in capital to back their ventures.
Fitting the digital demands of a global pandemic, it's a tech-heavy group, with liberal doses of biotech and healthcare-related firms.
MORE►
by Alex Edwards |
Feb 10, 2021
The agreement will involve the two companies providing educational programs and connections for scientist entrepreneurs located at the Biotech+ Hub at Pegasus Park.
MORE►
by Lauren Hawkins |
Dec 8, 2020
Dallas life science startups are invited to apply to ThinkLab's winter cohort, which will begin in late January 2021.
MORE►
The Eos Bioreactor sequesters carbon dioxide using algae. [Photo: Courtesy Hypergiant Industries]
The Art of Climate Tech: Fort Worth Museum Showcases Hypergiant’s AI-Powered, Carbon-Capturing Eos Bioreactor
by Sandra Engelland | Nov 10, 2020
The Eos Bioreactor, which also has been featured in Popular Mechanics, uses algae to "eat" CO2.
MORE►
by Lauren Hawkins |
Oct 27, 2020
The Dallas-based leader will receive the award from BionorthTX for his contributions to the field of life sciences.
MORE►
by Alex Edwards |
Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
by Quincy Preston |
Oct 8, 2020
This year's Nobel Prize in Chemistry, awarded to two female scientists for the development of CRISPR as a gene-editing tool, is a revolution, according to a pair of UTSW scientists.
UTSW's Eric Olson and Rhonda Bassel-Duby use the technology in their work to treat Duchenne muscular dystrophy. Olson also is the co-founder of biotech Exonics Therapeutics, which exited last year in a deal roughly valued at $1B.
MORE►
